Syngulon is a synthetic biology company that engineers bacteriocins – ribosomally-produced, genetically-encoded antimicrobial peptides for:
• Antibiotic-free genetic selection – Proprietary bacteriocin/immunity cassettes replace traditional antibiotic-resistance markers in recombinant protein and plasmid-DNA manufacturing
• Next-generation antimicrobials – Engineered bacteriocins as stand-alone or adjunct therapeutics to combat antimicrobial-resistant (AMR) pathogens in human health